Digital transformation in diagnostics: What’s next?
Alex ClementeManaging Director, Harvard Business Review Analytic Services
William Morice II, MD, PhDProfessor and Chair of the Department of Laboratory Medicine and Pathology, Mayo Clinic, and President of Mayo Clinic Laboratories
Nick de PenningtonDigital Innovation & Population Health Lead, Oxford University Hospitals, National Health Service Foundation Trust, and CEO, Ufonia
Digital transformation in diagnostics: What’s next?10 September 2020
Data-driven diagnostics has the potential to improve patient outcomes and the cost-effectiveness of healthcare
Many healthcare organizations recognize the tremendous potential of data, yet struggle to unlock its full power
In a recently conducted global survey by Harvard Business Review Analytic Services, senior healthcare leaders share key insights and practices to facilitate successful digital transformation
Seizing the potential of data-driven diagnostics
Harvard Business Review Analytic Services (HBRAS) recently conducted a global survey of senior healthcare leaders sponsored by Roche. It found that leaders worldwide recognized the tremendous potential of the advanced use of data to improve health outcomes and improve the efficiency and cost-effectiveness of healthcare.
However, many healthcare organizations are struggling to unlock the full power of data to drive decision making and improve performance.
In this webinar, Alex Clemente summarizes the HBRAS survey findings about data-driven diagnostics in healthcare as he discusses:
- Key survey takeaways, including the behaviors and characteristics that differentiate leaders from laggards in digital transformation
- Barriers to becoming more data driven
- Five practices that can facilitate transformation.
Following the presentation of the survey findings, Dr. William G. Morice of Mayo Clinic and Nick de Pennington of Oxford University Hospitals share their perspectives about digital transformation in healthcare, the challenges that must be overcome, and the impact of COVID-19.
Angelia Herrin, Editor, Special Projects and Research, Harvard Business Review Analytic Services